Montelukast Prescribing at PRIME PRACTICE PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
585
Total Quantity
12.7K
NHS Cost
£706
vs National Avg
-14.6%
PRIME PRACTICE PARTNERSHIP prescribed 585 items of Montelukast over the last 12 months at a cost of £706 to the NHS. This is 14.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
46
Jun 2026
40
Jun 2026
54
Jun 2026
39
Jun 2026
43
Jun 2026
60
Jun 2026
51
Jun 2026
44
Jun 2026
49
Jun 2026
47
Jun 2026
57
Jun 2026
55
Prescribing Details
| Total Items | 585 |
|---|---|
| Total Quantity | 12,656 |
| Total NHS Cost | £706 |
| Presentations | 4 different forms |
| vs National Average | -14.6% |
Montelukast Prescribing Comparison
| This practice | 585 items |
|---|---|
| National average per practice | 685 items |
| Difference | -14.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.